tbuckley/cabot-search huggingface dataset:
Incidence, Time to Diagnosis, and Therapeutic Landscape of Aplastic Anemia: Results from a Large United States Claims Database
Authors: Phillip Scheinberg, Tim H. H. Brummendorf, Regis Peffault De Latour, Carlo Dufour, Raj Gokani, Morag Griffin, Juliana Hey-Hadavi, Yoshinobu Kanda, Eric Mitchell, Barbara Możejko-Pastewka, Andres Quintero, Patryk Skowron, Meltem Kurt Yüksel, Alicia Rovó
Journal: Blood (2024)
Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy
Authors: Nicholas L.J. Chornenki, Afraa Mustafa Sulieman Fadul, Analiza Supan, Yasser Abou Mourad, Hannah Cherniawsky, Shanee Chung, Donna L. Forrest, Deepesh Pravinkumar Lad, Aly Karsan, Florian Kuchenbauer, Eric McGinnis, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Cynthia L. Toze, Jennifer White, Ryan J Stubbins
Journal: Blood (2024)
Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia
Authors: Lu-Lu Wang, Yu-Xiu Chen, Meng-Tong Zang, Jian-Ying Zhou, Meng-Yu Xiao, Hai-Xia Fu, Xiao-Dong Mo, Feng-Rong Wang, Wei Han, Yuan-Yuan Zhang, Chen-Hua Yan, Zhi-Dong Wang, Ting-Ting Han, Meng Lv, Huan Chen, Yu-Hong Chen, Yao Chen, Jing-Zhi Wang, Yu Wang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Hui Zhang
Journal: Blood (2024)
Venetoclax with Hypomethylating Agents Compared with Priming Regimens for Newly Diagnosed Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes: A Single Center Retrospective Study
Authors: Fangtong Liu, Chao-Ling Wan, Yu-Qing Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zihao Wang, Sheng-Li Xue, Haiping Dai
Journal: Blood (2024)
The Polymeric Drug Pamd-Ch17 Induces Mitochondrial Dysfunction and Has Anti-Leukemic Effects
Authors: Calvin Lam, Yiqian Wang, Victor Rivero, Jogdeo Chinmay, Ekta Kapoor, Siyuan Tang, Peng Xiao, Svetlana Romanova, David Oupicky, Kate Hyde
Journal: Blood (2024)
Epidemiology, Outcomes, and Healthcare Utilization in Acute Myeloid Leukemia: A Study Using the National Inpatient Sample - 2021
Authors: Srinishant Rajarajan, Kalaivani Babu, Alexander Helfand, Arya Mariam Roy, Asmi Chattaraj, Sruthi P Ramanan, Nithya Ramesh, Adanma Anji Ayanambakkam Attanathi, Amit Correa
Journal: Blood (2024)
Combined Human and In Vivo Analyses Implicate the Critical Importance of Acute Myeloid Leukemia Associated CD8 T Cells and Identifies Their Molecular Dysfunction
Authors: Y. Emily Chu, Matthew A Cottam, Chad R Potts, Kirsten M Dickerson, Matthew T Jenkins, Justin A Cartailler, Rui Lu, Stanley C. Lee, Ross L Levine, Robert L. Bowman, Robert Welner, P. Brent Ferrell
Journal: Blood (2024)
Initial Results from the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections
Authors: Saad Z. Usmani, Emily A. Semmel, Shandra James, William A. Wood, Mark A. Schroeder, David J. Chung, Aaron S. Rosenberg, Jeffrey A. Zonder, Samuel M. Rubinstein, Anita D'Souza, Thomas Martin, Ajai Chari, Ravi Vij, Ajay K. Nooka, Kenneth C. Anderson, Donna S. Neuberg, Kathleen Hewitt, Brendan M. Weiss, Levi D. Pederson, Andriy Derkach, Susan M. Geyer, Shaji Kumar
Journal: Blood (2024)
Exploring the Burden of Acute Myeloid Leukemia Attributable to Smoking in G20 Countries: A Three-Decade Analysis from the Gbd 2021
Authors: Dhruvkumar Gadhiya, Sravani Bhavanam, Priyadeep Kaur, Adit Alpesh Dharia, Saifullah Syed, Dharmik Patel, Vishva M Patel, Shamitha Hejmadi, Rutvik Raval, Vishrant Amin, Mohit Lakkimsetti, Juhi Patel, Hardik Dineshbhai Desai
Journal: Blood (2024)
Combination of Low White Blood Cell Count and Impaired Renal Function Is a Risk Factor for Higher Concentrations of Venetoclax and Prolonged Neutropenia in AML Patients with Venetoclax Combined Regimen: Real World Experience in the Japanese Cohort
Authors: Minoru Kanaya, Yuji Mukai, Mirei Kobayashi, Sayaka Kajikawa, Toma Suzuki, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Masanobu Morioka, Akio Mori, Toshihiro Matsukawa, Masahiro Onozawa, Goichi Yoshimoto, Mitsuru Moriyama, Sunggi Chi, Takanori Teshima, Yosuke Minami, Masato Honmma, Takeshi Kondo
Journal: Blood (2024)
Unveiling Clinical Potential: Exploring Cytogenomic Aberrations through Optical Genomic Mapping in Multiple Myeloma
Authors: J Christine Ye, Guilin Tang, Oren Pasvolsky, Melody R. Becnel, Mahmoud R. Gaballa, Krina K. Patel, Hans C. Lee, Sheeba K. Thomas, Donna M. Weber, Pei Lin, Robert Z. Orlowski
Journal: Blood (2024)
Clinical Implications of Ctdna-Based Minimal Residual Disease Detection in Newly Diagnosed Diffuse Large B-Cell Lymphoma
Authors: Jinhua Liang, Yi-fan Wu, Hao-Rui Shen, Jiazhu Wu, Jun-heng Liang, Liu-Qing Zhu, Hua Yin, Yue Li, Li Wang, Jianyong Li, Xu Wei
Journal: Blood (2024)
Extended Follow up and Immune Alterations in Patients with Classic Hodgkin Lymphoma (cHL) Treated with Frontline Single Agent Pembrolizumab Followed By AVD Chemotherapy
Authors: Pamela B. Allen, Latifa Bazzi, Bin Zhang, Qing Chen, Liron Barnea Slonim, Hatice Savas, Ranjana H. Advani, Andrew M Evens, Barbara Pro, Reem Karmali, Eric Mou, Robert Eisner, Robert Bayer, Leo I. Gordon, Jane N. Winter
Journal: Blood (2024)
Primary Mediastinal B Cell Lymphoma (PMBCL): A Multicentric Observational Study of Spanish Lymphoma Group Geltamo
Authors: Almudena Cabero Martínez, Ana García Bacelar, Begoña Mendibil Esquisabel, Javier Nuñez Cespedes, Ana Jiménez Ubieto, Eukene Gainza Gonzalez, Elena Perez Ceballos, Beatriz De La Cruz, Ana Garcia Noblejas, Paula Fernández-Caldas, Norma C. Gutierrez, Blanca Sánchez-González, Rocío Figueroa Mora, Alberto Lopez Garcia, Daniel García Belmonte, Maria Sanchez de Castro, Estefania Cerezo Velasco, Xabier Martin Martitegui, Hugo Daniel Luzardo Henríquez, Jordina Rovira, Luis Antonio Lopez Gomez, Jackeline Solano, Ana Torres Tienza, Maria Stefania Infante, Raquel Santiago Alonso, Raquel Del Campo, Dunia De Miguel Llorente, Alicia Roldán-Pérez, Emilia Pardal, Beatriz Gonzalez Mena, Miguel Ángel Rodríguez Gil, Nazaret Domínguez Velasco, Albert Blanco Juan, Maria Alejandra Blum Dominguez, Javier López Marin, María Peñarrubia-Ponce, Mariana Bastos-Oreiro, Alejandro Martín García-Sancho
Journal: Blood (2024)
Enhanced Detection of Pathogenic Germline Variants in Plasma Cell Disorders: Impact of a Targeted Genetic Counseling Referral Pathway
Authors: Saoirse Bodnar, Tehilla Brander, Zachary M Avigan, William Genthe, David Melnekoff, Alessandro Lagana, Jane Houldsworth, Shambavi Richard, Joshua Richter, Larysa J Sanchez, Cesar Rodriguez, Adriana Rossi, Hearn Jay Cho, Kenan Onel, Sundar Jagannath, Manisha Balwani, Samir Parekh, Santiago Thibaud
Journal: Blood (2024)
BCL2 Expression Correlates with New Molecular Classification of Anaplastic Large Cell Lymphoma
Authors: Jimena B. Gimenez, Min Shi, Naoki Oishi, Liuyan Jiang, Farah M. Salama, Jennifer R. Chapman-Fredricks, Weina Chen, Jagmohan Sidhu, Xiaojun Wu, Stephen M. Ansell, Guangzhen Hu, Andrew L. Feldman
Journal: Blood (2024)
Standardized Prophylactic Platelet Transfusion Dose for Infants Decreases Platelet Exposure without Increasing Bleeding or Transfusion Frequency
Authors: Kristen Coletti, Matthew Devine, Sekinah Ajiboye, Jennifer Taft, Jeffrey Schinella, Lori Spotts, Meagan Sheakoski, Shannon McGowan, Kathleen Gibbs, Carmelita Moultrie-Savage, Jaleah Hawkins, David F. Friedman, Michele P. Lambert, Christopher S. Thom
Journal: Blood (2024)
Genomic Characterization of Ibrutinib-Resistant Waldenström's Macroglobulinemia
Authors: Tina Bagratuni, Christos Vlachos, Maria Sakkou, Ioannis Kollias, Ourania Theologi, Nefeli Mavrianou Koutsoukou, Christine-Ivy Liacos, Kostantina Taouxi, Alexandra Papadimou, Katerina Chrisostomidou, Despina Fotiou, Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis, Meletios-Athanasios Dimopoulos
Journal: Blood (2024)
Clinical Features and Prognostic Nomogram for Therapy-Related Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Menglin Li, Yi-Meng Li, Qingyuan Qu, Yuxiu Chen, Jianying Zhou, Mengyu Xiao, Chencong Wang, Qi Chen, Xiaolu Zhu, Yun He, YuanYuan Zhang, Qian Jiang, Hao Jiang, Jin Lu, YingJun Chang, Xiaosu Zhao, Xiangyu Zhao, Xiao Jun Huang, Xiaohui Zhang
Journal: Blood (2024)
A Comprehensive Analysis of FLT3 Mutation Profiles and Clinical Outcomes in Adult Patients with Acute Myeloid Leukemia: A Single Institution Experience
Authors: Jessica El-Asmar, Daniel P. Nurse, Ameed Bawwab, Yomna Abu-Farsakh, Moath Albliwi, John Hanna, Asad Rauf, Hasan Abuamsha, Heya Batah, Emily C. Zabor, Yohana B. Bedelu, Mark Jinan Chen, Joy Nakitandwe, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Sudipto Mukherjee, Anjali S. Advani, Hetty E. Carraway, Moaath K. Mustafa Ali
Journal: Blood (2024)
Shallow Whole Genome Sequencing of Circulating Tumor DNA Is Predictive of Outcome in Diffuse Large B-Cell Lymphoma
Authors: Davidson Zhao, Victoria Shelton, Inna Gong, Juan Rangel-Patiño, Ting Liu, Michael Hong, Vanessa Murad, Ur Metser, Anca Prica, Vishal Kukreti, Sita Bhella, Abi Vijenthira, Michael Crump, John Kuruvilla, Bernard Lam, Robert Kridel
Journal: Blood (2024)
Patient-Derived Follicular Lymphoma Tumoroids: A Tool to Recapitulate Biological Features of Low and High-Grade Lymphoma
Authors: Ruben Gimenez, Neus Serrat, Miquel Castellote-Borrell, Victor Jiménez-Martínez, Eduardo Pérez del Río, Mireia Bachiller, Ferran Araujo-Ayala, Raul F Pérez, Ares Martínez-Farran, Jose Ángel Robles, Armando Lopez-Guillermo, Elias Campo, Josep Villanueva, Sonia Guedan, Jose Ignacio Martin-Subero, Judith Guasch, Daniel J Hodson, Dolors Colomer, Patricia Pérez Galán
Journal: Blood (2024)
Predictive Modeling of Clonal Hematopoiesis across Diverse Cohorts
Authors: Armel L. Batchi-Bouyou, Duc Tran, Michael Raddatz, Teng Gao, Caitlyn Vlasschaert, Brian Sharber, Jie Liu, Giulia Petrone, Irenaeus C.C. Chan, J. Scott Beeler, Griffen Mustion, Sean M. Devlin, Alexander G. Bick, Kelly Bolton
Journal: Blood (2024)
Acuity of Illness at Initial Presentation Mediates Early Mortality in Adolescent and Young Adult Leukemia
Authors: Tarun Jain, Xu Ji, Nicholas Degroote, Alexandra Himes, Cortland Coxhead, Rebecca Williamson Lewis, Anjali Khanna, Alexandra Cathcart, Tamara P. Miller, Kristie A. Blum, Keiko Tarquinio, Sharon M. Castellino
Journal: Blood (2024)
Characteristics and Outcomes of Incidentally Diagnosed Diffuse Large B Cell Lymphoma (DLBCL)
Authors: Suheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, Robyn L Kuchler, Thomas M. Habermann, Matthew J. Maurer, James R. Cerhan, Carrie A Thompson, Yucai Wang, Grzegorz S. Nowakowski, Stephen M. Ansell, Thomas E. Witzig
Journal: Blood (2024)
Efficacy and Safety of Polatuzumab-Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) for Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Real-World, Multi-Center, Retrospective Cohort Study
Authors: Zhao Peiqi, Shu Zhao, Chen Huang, Jiesong Wang, Junqing Xu, Lanfang Li, Zhengzi Qian, Wei Li, Shiyong Zhou, Lihua Qiu, Xianming Liu, Ying Chen, Yanan Jiang, Yanbin Zheng, Daoguang Chen, Yuhuan Gao, Qingyuan Zhang, Huilai Zhang
Journal: Blood (2024)
Updated Results from a Multicenter, Phase II Study of Zanubrutinib in Combination with Rituximab and Methotrexate, Followed By Zanubrutinib Maintenance in Patients with Secondary Central Nervous System Lymphoma
Authors: Lijuan Deng, Tianheng He, Yongjing Tang, Lan Mi, Changyu Lu, Hanxiao Liu, Shupeng Zhong, Jin Chai, Jun Luo, Liling Zhang, Shujuan Wen, Xiaopei Wang, Jun Zhu, Yuqin Song
Journal: Blood (2024)
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged over 70 Years with Myelofibrosis
Authors: Moazzam Shahzad, Muhammad Kashif Amin, Ben Ponvilawan, Hana Qasim, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Abat Khan, Abdulraheem Yacoub, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2024)
Long-Term Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Resistant Ph+ Acute B Lymphoblastic Leukemia That Cannot Get MRD- Remission after Multi-Line Treatment
Authors: Yanzhi Song, Erhui Yuan, Qishu Qin, Qi Wang, Zhanxiang Liu, Kong Gao, Zhihui Li, Yongqiang Zhao, Tong Wu
Journal: Blood (2024)
Etavopivat Increases Arterial Hemoglobin-Oxygen Saturation during Moderate and Severe Hypoxia: A Mechanistic Phase 1 Trial in Healthy Volunteers
Authors: Chad Wiggins, Kevin L. Webb, Jacob L. Gasner, Wyatt W. Pruter, Sunil Navani, Marcus A. Carden, Michael J. Joyner
Journal: Blood (2024)
CD19 CAR-T Therapy for Patients with Relapsed or Refractory Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study
Authors: Jinglei Yu, Fengmei Song, Mingming Zhang, Mingfeng Zhao, Wei Sang, Songfu Jiang, Lixin Wang, Xingbing Wang, He Huang, Yongxian Hu, Guoqing Wei
Journal: Blood (2024)
Impact of Bone Marrow Evaluation Using Bone Marrow Biopsy, Flow Cytometry, and PET/CT in B-Cell Non-Hodgkin Lymphomas
Authors: José Antonio Sánchez Salas, Estela Ruiz Ruiz, Almudena Cascales Hernandez, Joaquin Gomez Espuch, Andrea Poveda Garcia, Angela Heredia Cano, Miguel Blanquer Blanquer, Maria Carmen GARCIA Garay, Antonio Jose Martinez Mellado, Alfredo Minguela Puras, Agueda Bas Bernal, Vanessa Roldan Schilling, Antonio Salar Silvestre
Journal: Blood (2024)
CD20xCD3 Bispecific Antibodies As Standard of Care (SOC) for Relapse/Refractory (R/R) Large B-Cell Lymphoma (LBCL) - a Multicenter Retrospective Study
Authors: Ning Dong, Sushmita Khadka, Jose Sandoval-Sus, Carlos Silva Rondon, Ariel Perez, Tiba Al Sagheer, Madiha Iqbal, Juan Pablo Alderuccio, Cristian Rodriguez Arocho, Syeda Saba Kareem, Michael D. Jain, Julio C. Chavez
Journal: Blood (2024)
Orelabrutinib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Who Are Intolerant to Prior Bruton Tyrosine Kinase Inhibitors (BTKi): Updated Results from a Phase 2 Study
Authors: Lin Shen, Jing Bao, Lihong Shou, Ying Lu, Qi Zhu, Li Wang, Weili Zhao
Journal: Blood (2024)
Improved Survival with Daratumumab-Cybord Compared to Cybord As Frontline Therapy in Immunoglobulin Light Chain (AL) Amyloidosis
Authors: Binoy Yohannan, Matthew James Rees, Morie A. Gertz, Angela Dispenzieri, Francis Buadi, David Dingli, Nelson Leung, Prashant Kapoor, Wilson I. Gonsalves, Taxiarchis Kourelis, Joselle Cook, Moritz Binder, Martha Lacy, Suzanne R Hayman, Yi Lin, Yi Lisa Hwa, Michelle G Rogers, Miriam Hobbs, Amie Fonder, Ronald S Go, Rahma M Warsame, Vincent Rajkumar, Shaji Kumar, Eli Muchtar
Journal: Blood (2024)
26S Proteasome Non-Atpase Subunit 3 (PSMD3/Rpn3) Is a Potential Therapeutic Target in Multiple Myeloma
Authors: Teng Fang, Yan Song, Ting Du, Arghya Ray, Xueping Wan, Minxing Wang, Sindhu C Pillai, Md. Abu Musa, Mu Hao, Lugui Qiu, Dharminder Chauhan, Kenneth C. Anderson
Journal: Blood (2024)
Real-World Experience with Isatuximab in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Iona-MM Second Interim Analysis
Authors: Mahmoud R. Gaballa, Thomas G Martin, Nobuhiro Tsukada, Kazuhito Suzuki, Hirono Iriuchishima, Emilie Chalayer, Vincent Camus, Maria Magdalena Alcala Peña, Anna Furlan, Max Christian Georg Hubmann, Wolfgang Ulrich Knauf, Christina Tekle, Ani Minasyan, Chunfu Qiu, Meral Beksac
Journal: Blood (2024)
Comparative Efficacy and Safety of Ciltacabtagene Autoleucel and Idecabtagene Vicleucel in Real-World Relapsed/Refractory Multiple Myeloma: A Retrospective Intention-to-Treat Analysis
Authors: Behzad Amoozgar, Ayrton I Bangolo, David H. Vesole, David S. Siegel, Noa Biran, Pooja Phull, Michele L. Donato, Harsh Parmar
Journal: Blood (2024)
Role of B Cell Recovery in Relapse Risk and CD19 Phenotype Following Real-World Use of Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia: A Multi-Institutional Retrospective Study
Authors: Xiaopei Lily Zeng, Soyang Kwon, Anant Vatsayan, Christina Baggott, Snehit Prabhu, Samuel John, Holly L. Pacenta, Christine L. Phillips, Jenna Rossoff, Julie-An Talano, Amy Moskop, Michael R Verneris, Douglas D. Myers, Erin Marie Hall, Nicole A Karras, Challice L. Bonifant, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K Keating, Susanne H.C. Baumeister, Vanessa A. Fabrizio, Vasant Chinnabhandar, Emily Egeler, Sharon Mavroukakis, Khanh Nguyen, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora Michal Schultz, Kevin O. McNerney
Journal: Blood (2024)
Health-Related Quality of Life in Adolescents and Young Adults Treated with Blinatumomab Consolidation for CD19+ Ph-Negative Acute Lymphoblastic Leukemia in the Australasian Lymphoma and Leukaemia Group (ALLG) ALL09 “Sublime” Study
Authors: Omali Pitiyarachchi, Madeleine T King, Shane Gangatharan, Michael Osborn, Ashley P Ng, Shaun Fleming, Pasquale Fedele, Toby N Trahair, John Casey, Sally Mapp, Carol CY Cheung, Tasman Armytage, Philip McCloud, Peter Button, Leesa Rowley, Stephen Robert Larsen, Peter Presgrave, John Kwan, Samuel Bennett, Chun Yew Fong, Luciano Dalla-Pozza, Matthew Greenwood
Journal: Blood (2024)
“As Treated” Validation of the European LeukemiaNet (ELN) Classification for Adult Acute Myeloid Leukemia (AML) Patients (pts) Treated in a Large AML-Referral Center from 2010-2022
Authors: Andrew F. Berdel, Julian Ronnacker, Daniela V. Wenge, Lina Kolloch, Philipp Berning, Linus Angenendt, Tobias Brix, Annette Westermann, Klaus Wethmar, Torsten Kessler, Andrea Kerkhoff, Rolf M. Mesters, Christian Reicherts, Jan-Henrik Mikesch, Wolfgang E. Berdel, Georg Lenz, Christoph Schliemann, Matthias Stelljes
Journal: Blood (2024)
Prognostic Significance of <i>TP53</i> Mutations in Lymphoplasmacytic Lymphoma
Authors: Anath Lionel, Sherif Seif, Xiaowen Sun, Lei Feng, Lorenzo Gensini, Bria Gabriel, Lauren S. Lewis, Hima Bansal, Melody R. Becnel, Mahmoud R. Gaballa, Hans C. Lee, Oren Pasvolsky, Krina K. Patel, J Christine Ye, Keyur P. Patel, Donna M. Weber, Robert Z. Orlowski, Sheeba K. Thomas
Journal: Blood (2024)
Ponatinib Monotherapy after Combination with Chemotherapy in Patients with Newly Diagnosed Ph+ ALL: Post Hoc Subgroup Analysis of the Phase 3 Phallcon Study
Authors: Elias Jabbour, Hagop M. Kantarjian, Ibrahim Aldoss, Pau Montesinos, Jessica T. Leonard, David Gomez-Almaguer, Maria R. Baer, Carlo Gambacorti-Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Lin Yang, Meliessa Hennessy, Alexander Vorog, Niti Patel, Tammie Yeh, Josep-Maria Ribera
Journal: Blood (2024)
Augmented Hyper-CVAD (AHCVAD), a Pediatric Inspired Regimen for Adults Younger Than 50 Years of Age with Acute Lymphoblastic Leukemia (ALL), Yields High Rates of MRD Negativity, Favorable 3-Year Overall Survival Regardless of Allogeneic Stem Cell Transplant (ASCT): A Single Center Experience
Authors: Sarvarinder Kaur Gill, Geeny Lee, Joelle Rubin, Shuqi Wang, Jamie Koprivnikar, Katherine Linder, James McCloskey
Journal: Blood (2024)
Superiority in the Longer Duration of Response and Better Central Nervous System Penetration of CAR-T Cell Therapy over Blinatumomab Infusion for Relapsed/ Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis
Authors: Yuhang Cheng, Xueyan Sun, Meijuan Huang, Lei Zhao, Jue Wang, Hanyu Wang, Wanying Liu, Shanwei Ye, Liang Huang, Gaoxiang Wang, Yang Cao
Journal: Blood (2024)
The Chromatin Accessibility Landscape and Regulatory Network of CD34 Positive Cells in Acute Myeloid Leukemia
Authors: Wenbing Liu, Yu Liu, Anli Lai, Runxia Gu, Ying Wang, Qing Rao, Yingchang Mi, Hui Wei, Shaowei Qiu, Min Wang, Jianxiang Wang
Journal: Blood (2024)
Efficacy and Safety of Cyclosporine Monotherapy for Patients with Non-Severe Aplastic Anemia Not Requiring Transfusions: Results from a Prospective Multicenter Phase II Study
Authors: Naoko Hosono, Ken Ishiyama, Hiroki Yamaguchi, Masahide Yamazaki, Hiroyuki Maruyama, Kensuke Usuki, Kazuki Tanimoto, Hiroyuki Sugiura, Noboru Asada, Seishi Ogawa, Yuzuru Kanakura, Itaru Matsumura, Koichi Akashi, Shinji Nakao
Journal: Blood (2024)
Should “Medically Fit” Older Patients with Acute Myeloid Leukemia (AML) Continue to Receive Intensive Chemotherapy in the Venetoclax (VEN) Era?
Authors: Nilesh Kapoor, Ang Gao, Ruth Ikpefan, Chul Ahn, Julia Anderson, F Neslihan Kalkan, Weina Chen, Sharon Germans, Alejandro Marinos Velarde, Vivian Irrizary Gatell, Julio Alvarenga Thiebaud, Clayton Jackson, Olga K. Weinberg, Miguel Cantu, Robert H. Collins, Stephen Chung, Yazan F Madanat
Journal: Blood (2024)
Racial Disparities in Survival Outcomes of Diffuse Large B Cell Lymphoma: A Retrospective Cohort Study from 2000 to 2021
Authors: Oboseh John Ogedegbe, Asfand Yar Cheema, Ahmed Bashir Sukhera, Gloria Erazo, Jorge Rodriguez Vazquez, Serhan Unlu, Tabowei Godfrey
Journal: Blood (2024)
Deep Learning Predicts Response to Venetoclax and Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia Solely Based on Bone Marrow Smear Image Data
Authors: Jan-Niklas Eckardt, Ishan Srivastava, Yeqiao Xu, Kellen B Gil, Andrea A. Osypuk, Zenggang Pan, Martin M. K. Schneider, Freya Schulze, Karsten Wendt, Susann Winter, Martin Bornhäuser, Daniel A. Pollyea, Jan Moritz Middeke
Journal: Blood (2024)
MS4A3 Serves As a Biomarker Reflecting the Lineage Differentiation and Metabolic Status of Human Acute Myeloid Leukemia Cells
Authors: Hidenori Kasahara, Takafumi Yokota, Jun Nakayama, Henyun Shi, Yusuke Imagawa, Toru Hiratsuka, Keiko Takano, Yasuhiro Shingai, Shigeki Higashiyama,
Journal: Blood (2024)
Steric Hindrance By APRIL in Binding of BCMA-Directed Bispecific Antibodies: A Novel Refractory Mechanism of BCMA-Directed Immunotherapies in Multiple Myeloma
Authors: Takeshi Harada, Yusuke Inoue, Asuka Oda, Jumpei Teramachi, Yusaku Maeda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Hikaru Yagi, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shuji Ozaki, Ken-ichi Matsuoka, Masahiro Abe
Journal: Blood (2024)
CDK4/6 Inhibition Reverses MEIS2 Inhibition of CRL4CRBN By Both Disrupting MEIS2-CRBN Association and Opposing Regulation of MEIS2 and CRBN Synthesis That Enhances IMiD Therapy in Multiple Myeloma
Authors: Xiangao Huang, David S Jayabalan, Maurizio Di Liberto, Zhengming Chen, Scott Ely, Roger Pearse, Joseph Lane, Gang Lin, Ruben Niesvizky, Selina Chen-Kiang
Journal: Blood (2024)
Clinical Implications of Plasma-Derived Extracellular Vesicles in Myeloproliferative Neoplasms: Unveiling Inflammatory Potential and Biomarkers for Cancer Treatment
Authors: Ghazal Narimanfar, Dorian Forte, Roberto Maria Pellegrino, Francesca Perut, Filippo Maltoni, Martina Barone, Alessia Brancolini, Filippo Branzanti, Virginia Pucci, Elisabetta Lugli, Alessia Tieghi, Carla Emiliani, Regina Grillari, Pier Luigi Zinzani, Francesca Palandri, Lucia Catani
Journal: Blood (2024)
Anti-CD117 Plus Anti-Sirpα or Fc-Silenced Anti-CD47 Enables Hematopoietic Stem Cell Depletion and Syngeneic Engraftment without Development of Severe Anemia
Authors: Stephen P. Persaud, Aditya R. Yelamali, Julie K. Ritchey, John F. DiPersio
Journal: Blood (2024)
Ribosome Profiling Sequencing Reveals LPIN1 As a Potential Therapeutic Target for Acute Myeloid Leukemia with FLT3 -ITD Mutation
Authors: Gao Yuang, Qianyu Zhang, Zhichun Lv, Shuhong Liu, Yide Sun, Huiying Gao, Xiongwei Zhao, Xin Li, Yang Xue, Hao Li, Changyan Li, Hongmei Ning
Journal: Blood (2024)
Clonal Hematopoiesis Mutations and Cell-Free DNA Characteristics in Patients with High-Risk Large B-Cell Lymphomas
Authors: Miro Nylén, Leo Meriranta, Emil Hiitola, Maare Arffman, Harald Holte, Judit Mészáros Joergensen, Peter Brown, Sirkku Jyrkkiö, Mats Jerkeman, Øystein Fluge, Magnus Björkholm, Lars Møller Pedersen, Mikael Eriksson, Satu Mustjoki, Sirpa Leppä, Mikko Myllymäki
Journal: Blood (2024)